Latest Glycogen storage disease type II Stories
LEXINGTON, Mass., March 30, 2015 /PRNewswire/ -- Synageva BioPharma Corp. (NASDAQ: GEVA), a biopharmaceutical company developing
MDA, Genzyme and Emory University team up to expand access to genetic testing for accurate diagnosis of limb-girdle muscular dystrophy CHICAGO, March 26, 2015 /PRNewswire-USNewswire/
LEXINGTON, Mass., Feb.
NEW YORK, July 7, 2014 /PRNewswire/ -- Lysosomal storage disorders are a group of approximately 50 rare inherited metabolic disorders resulting from defects in lysosomal function.
Three neuromuscular diseases are being considered for inclusion in nationwide screening. Tucson, AZ (PRWEB) September 27, 2013 Pediatrician and medical
Kids with Pompe disease fail because of a missing enzyme, GAA, that leads to dangerous sugar build-up, which affects muscles and movement.
- A serpent whose bite was fabled to produce intense thirst.